Testing effectiveness (Phase 2)Study completedNCT00084630
What this trial is testing
Imatinib Mesylate in Treating Patients With Locally Recurrent or Metastatic Dermatofibrosarcoma Protuberans
Who this might be right for
Adult FibrosarcomaDermatofibrosarcoma ProtuberansRecurrent Adult Soft Tissue Sarcoma+1 more
National Cancer Institute (NCI) 40